发明名称 QUINOLINE DERIVATIVES AS CASPASE-3 INHIBITOR, PREPARATION FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
摘要 The present invention relates to new quinoline derivatives of formula (1) or their pharmaceutically acceptable salts with caspase-3 inhibitory activity and their preparation methods, wherein R<SUB>2 </SUB>is H; halogen; C<SUB>1-6</SUB>alkyl; C<SUB>1-6 </SUB>alkoxy; C<SUB>1-6 </SUB>alkoxyalkyl; or C<SUB>3-6</SUB>cycloalkyl; R<SUB>1 </SUB>is formula (a); -CN; or formula (b); R is H; C<SUB>6-14</SUB>aryl unsubstituted or substituted by halogen, C<SUB>1-6 </SUB>alkyl, C<SUB>1-6 </SUB>alkoxy or amino; 5-15 membered heterocyclic group unsubstituted or substituted by halogen, C<SUB>1-6 </SUB>alkyl, C<SUB>1-6 </SUB>alkoxy or amino; or -(CH<SUB>2</SUB>)<SUB>n</SUB>-CHR<SUB>4</SUB>R<SUB>5</SUB>. The present invention relates to a pharmaceutical composition for treating caspase-associated diseases by inhibiting the activity of caspase-3 which comprises the compound of formula (1) or its pharmaceutically acceptable salt.
申请公布号 EP1499593(A4) 申请公布日期 2006.02.01
申请号 EP20030721128 申请日期 2003.04.30
申请人 YUNGJIN PHARMACAUTICAL CO., LTD.;KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY 发明人 KIM, SUNG-GYU;JUNG, YOON-SUNG;KONG, JAE-YANG;PARK, WOO-KYU
分类号 C07D215/44;C07D215/46;A61K31/47;A61K31/4706;A61K31/4709;A61K31/5377;A61P9/08;A61P19/00;A61P19/02;A61P21/04;A61P25/00;A61P25/08;A61P25/14;A61P25/16;A61P25/28;A61P31/18;A61P43/00;C07D215/42;C07D215/54;C07D401/12;C07D405/12;C07D409/12 主分类号 C07D215/44
代理机构 代理人
主权项
地址